Loss or reduced expression of E-cadherin has been shown to be associated wi
th poor survival in patients with bladder cancer. In numerous cases, loss o
f E-cadherin expression in bladder tumors has been accompanied by continued
association of catenins with the membrane, suggestive of the expression of
an alternative cadherin member. In this study we examined 75 bladder tumor
s using immunohistochemistry for the expression of E-, P-cadherin, and alph
a-, beta-, and gamma -catenins. As reported previously, loss or reduced E-c
adherin expression is a frequent event in late stage bladder cancer, accomp
anied by less frequent alterations associated with different catenin family
members. Analysis of 51 tumors for expression of E-, P-, and N-cadherin sh
owed P-cadherin localized to the basal cell layers of normal urothelium, wi
th retention of expression in the majority of tumors. In low-grade tumors P
-cadherin was found localized to an expanded basal cell compartment, contra
sting with the more extensive staining observed in late stage tumors. Membr
anous P-cadherin staining was often found in the absence of E-cadherin stai
ning. N-cadherin is not expressed in normal bladder mucosa, but detection o
f this cadherin member was recorded in 39% (20/51) of bladder tumors. Unlik
e P-cadherin, membranous N-cadherin was detected in focal regions within tu
mors, representing novel expression in urothelial neoplastic progression. A
lthough focal N-cadherin staining was observed in 3 noninvasive lesions, th
e majority of tumors expressing N-cadherin were invasive (17/20). Coexpress
ion of E-, P-, and N-cadherin was recorded in 5 grade 2 bladder tumors. Exp
ression of P-cadherin is maintained throughout bladder tumorigenesis, accom
panied by aberrant expression of N-cadherin. Clearly, neither P- nor N-cadh
erin act in an invasive-suppressor mode in bladder cancer, but whether they
have a primary role to play in urothelial neoplastic progression has yet t
o be established. Copyright (C) 2001 by W.B. Saunders Company